TY  - GEN
AU  - Davey,P
AU  - Craig,A M
AU  - Hau,C
AU  - Malek,M
TI  - Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized, placebo-controlled trial
SN  - 0305-7453
PY  - 1999///1026
KW  - Administration, Intranasal
KW  - Anti-Bacterial Agents
KW  - administration & dosage
KW  - Belgium
KW  - Cost-Benefit Analysis
KW  - Female
KW  - France
KW  - Health Care Costs
KW  - Humans
KW  - Length of Stay
KW  - economics
KW  - Male
KW  - Mass Screening
KW  - Middle Aged
KW  - Mupirocin
KW  - Peritoneal Dialysis
KW  - Staphylococcal Infections
KW  - drug therapy
KW  - Staphylococcus aureus
KW  - drug effects
KW  - United Kingdom
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/jac/43.1.105
ER  -